National Medical Insurance Administration: Launching pilot work on real-world comprehensive value evaluation of medical insurance

The Office of the National Healthcare Security Administration issued a notice, deciding to carry out a pilot project for comprehensive value evaluation of medical insurance in some pioneering regions in the real world. The pilot work should adhere to unified norms, with the National Healthcare Security Administration coordinating deployment and local exploration and practice, gradually constructing a unified national evaluation system. It should adhere to data empowerment, value real-world data and evidence, use reliable, usable, and trustworthy real-world data as a basis, ensure the scientificity, objectivity, and transparency of evaluation. It should adhere to comprehensive assessment, based on the entire lifecycle of pharmaceuticals and healthcare before and after listing, before and after market access, before and after renewal, before and after project approval, comprehensively evaluating the comprehensive value of pharmaceutical products from multiple dimensions such as clinical effectiveness, safety, economy, fairness, accessibility, innovation, and patient experience. It should adhere to practical application, strengthen the application of evaluation results, improve the efficiency of medical insurance fund utilization, enhance the efficiency of medical insurance management services, and empower the high-quality development of the pharmaceutical industry.